Goldman Sachs Downgrades Aetna (AET) to Sell
More News related to AET
- Aetna Teams up with Bishop Eddie Long to Spread the Word about Preventing and Managing Diabetes
- Aetna (AET) Announces One-Year Contract Renewal with Memorial Hospital
- Aetna Signs New Agreement with Memorial Hospital
- Black Enterprise Magazine Names Aetna as One of the Best Companies for Diversity
- Aetna Honored for Support of the Guard and Reserve
More News related to Downgrades
- Jefferies Downgrades Discovery Lab (DSCO) Two-Notches To Underperform
- Credit Suisse Downgrades FPL Group (FPL) to Neutral
- Jefferies & Co Downgrades Blackbaud (BLKB) to Hold
- JP Morgan Upgrades Franklin Resources (BEN) and T.Rowe (TROW), Downgrades FII, EV
- Goldman Sachs Downgrades Group 1 Automotive (GPI) to Neutral On Valuation
Goldman Sachs downgrades Aetna Inc. (NYSE: AET) from Neutral to Sell.
Aetna, Inc. operates as a diversified health care benefits company primarily in the United States and Canada.
Related Categories
DowngradesStocks Mentioned
+3.21Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
